SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cash Cat

A sharp pullback after CASHCATs earlier meme-coin rally and record-high run is driving attention, with traders debating whether the move reflects profit-taking and short-term manipulation or a broader Robinhood-chain accumulation thesis. Bulls point to alleged buybacks, burns, utility and growing holder activity, while bears characterize the token as a volatile pump-and-dump with weakening support.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

A Ninth Circuit ruling that sports-event contracts can be treated as gambling rather than federally regulated swaps is driving attention, as traders see a potential reduction in Kalshi and other prediction-market competition for DraftKings. The community remains divided over whether the decision will strengthen DraftKings regulatory moat or create further uncertainty pending possible Supreme Court review, with NFL-season betting activity adding context.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

Uncertainty over BlueBird 11s status and the lack of shipment or launch updates are driving attention, with traders questioning AST SpaceMobiles execution and delayed constellation rollout. The community is split between speculation that the satellite or production cadence is impaired and optimism that BB11 is functioning and that upcoming launch news could address the concerns; insider selling and a reported class-action lawsuit add to the debate.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

A sharp rebound and elevated trading volume have renewed attention on ALGO, with traders highlighting Algorands new CEO, v5 mainnet upgrade with post-quantum accounts, and recent Robinhood availability as potential catalysts. Skeptics argue that weak adoption, foundation selling and dilution could continue to cap rallies.

Hunter Biden’s Laptop (LAPTOP) is a memecoin referencing the eponymous Hunter Biden laptop sensation that’s been a fixture in global media news cycles for the past six years. LAPTOP is a fungible, freely transferable, non-yield-bearing ERC-20 token on Base. As a memecoin, LAPTOP has no utility, but incorporates two novel distribution mechanics designed to promote long-term community growth: a large community airdrop and an event-based supply mechanism.

Hunter Biden's Laptop

The Hunter Biden-themed memecoin is drawing attention after a rapid post-launch collapse that traders widely describe as a rug pull, with debate over liquidity, allocations, and whether the token was technically disrupted or deliberately dumped. Most discussion is negative and focused on losses, though a smaller group is speculating about a rebound or attempting to short the volatility.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Uncertainty surrounding the U.S. CLARITY Act is the dominant discussion, with traders debating whether a delay or failure would weigh on HBAR while passage could improve regulatory confidence across crypto. The community is split between bullish accumulation and expectations of further weakness, citing muted volume, resistance levels, and broader market conditions.

Astera Labs, Inc. provides rack-scale AI infrastructure through purpose-built connectivity solutions. The company offers a range of semiconductor-based connectivity solutions designed to address bandwidth, latency, and reliability challenges in AI and cloud data centers. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

Strong quarterly results, raised guidance, and a faster Scorpio AI-fabric ramp are driving renewed attention, alongside a wave of analyst upgrades tied to sustained AI infrastructure and data-center connectivity spending. Traders remain divided, with bulls viewing the pullback as a buying opportunity while skeptics cite elevated valuation, margin pressure, and volatile price action.

Direxion Shares ETF Trust - Direxion Daily Junior Gold Miners Index Bull 2X ETF

Renewed interest in gold and junior miners is being driven by traders concerns over persistent inflation, expanding U.S. deficits, Treasury/Fed liquidity measures and geopolitical risk, with JNUG viewed as leveraged exposure to a potential safe-haven and hard-asset rotation. The community remains divided between bullish calls for further gains and warnings that JNUGs leverage and recent volatility could produce a sharp pullback.

Oscar Health, Inc. is a healthcare insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Managements Investor Day guidance updateraising the fiscal 2026 outlook, improving medical loss ratio expectations, and outlining long-term membership, margin, and revenue expansionis driving attention. Traders are broadly bullish on Oscars improving operating leverage and ACA share gains, though skeptics remain concerned about risk-adjustment exposure, future pricing and enrollment, and whether profitability improvements can persist.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets, Data Centers, and Treasury and Corporate. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The Treasury and Corporate segment includes the company’s proprietary trading and mining activities, as well as the company’s principal investments and related gains and losses. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

Anticipation of a new hyperscaler tenant for Galaxys Helios AI data center is the dominant catalyst, with traders also weighing the mixed ERCOT power classifications and broader crypto strength. Bulls expect a lease announcement to improve sentiment, while skeptics remain concerned about the delay, limited communication, and execution risk.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Editas (EDIT) Up 6.2% Since Last Earnings Report: Can It Continue?

Editas (EDIT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

4 Gene-Editing Biotech Stocks Worth Watching for Long-Term Gains

CRSP, NTLA, BEAM and EDIT offer distinct gene-editing opportunities, spanning commercial validation, late-stage catalysts and promising early-stage programs.

Is Editas Medicine (EDIT) Outperforming Other Medical Stocks This Year?

Here is how Editas Medicine (EDIT) and Amylyx Pharmaceuticals, Inc. (AMLX) have performed compared to their sector so far this year.

EDIT Q2 Earnings Beat Estimates, Revenues Rise, Pipeline in Focus

Editas beats Q2 estimates as collaboration revenues surge, while EDIT-401 advanced toward clinical testing with encouraging preclinical data.

Editas Medicine (EDIT) Reports Q2 Loss, Beats Revenue Estimates

Editas (EDIT) delivered earnings and revenue surprises of +50.00% and +524.80%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Geron (GERN) Reports Q2 Loss, Beats Revenue Estimates

Geron (GERN) delivered earnings and revenue surprises of -100.00% and +4.49%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Why Is Editas (EDIT) Down 12.4% Since Last Earnings Report?

CRISPR Therapeutics vs. Editas Medicine: Which Gene Editing Stock Is a Better Buy in 2026?

CRISPR Therapeutics vs. Editas Medicine: Which Gene Editing Stock Is a Better Buy in 2026...

Abercrombie & Fitch Upbeat Q1 Earnings, Joins Digital Turbine, Dycom Industries And Other Big Stocks Moving Higher On Wednesday

Dow Jones up 300 points with gains from Abercrombie & Fitch, Digital Turbine, Dycom Industries, Qfin Holdings, Editas Medicine, and others.read more...

EDIT's Q1 Loss Narrower Than Expected, Pipeline in Focus

Editas narrows Q1 loss as costs fall, but revenues drop sharply. Pipeline focus shifts to in vivo gene editing and lead candidate EDIT-401.

Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu on September 3, 2013 and is headquartered in Cambridge, MA.

Editas Medicine Inc

Editas Medicine Stock Slides After-Hours On Bigger-Than-Expected Q4 Loss, But Retail Bulls Eye M&A Potential

Equity

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	-$0.19	--	--	N/A
Q2 '26	-$0.18	-$0.15	16.47%	BEAT
Q1 '26	-$0.26	-$0.26	1.15%	BEAT
Q4 '25	-$0.23	-$0.06	74.21%	BEAT
Q3 '25	-$0.30	-$0.28	5.45%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

EDIT Earnings

Upcoming Earnings: Q3 '26

Historical Earnings